Medicare Part B Policy Change effective January 1, 2019

Under the new policy to beginning January 1, 2019, Medicare Advantage enrollees may be required to use lower-cost alternatives to more expensive drugs for new prescriptions for medications administered by a physician or in a clinical setting. The Centers for Medicare & Medicaid Services (CMS) announced new guidance allowing Medicare Advantage plans – “may use step therapy for Part B drugs as part of a patient-centered care coordination program.” Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or



Leave a Reply